Vetera WNV (Canada)

This page contains information on Vetera WNV for veterinary use.
The information provided typically includes the following:
  • Vetera WNV Indications
  • Warnings and cautions for Vetera WNV
  • Direction and dosage information for Vetera WNV

Vetera WNV

This treatment applies to the following species:
Manufacturer: Boehringer

West Nile Virus Vaccine, Killed Virus

Veterinary Use Only

Vetera WNV Indications

For vaccination of healthy horses 4 months of age or older as an aid in the prevention of viremia and mortality, and an aid in the reduction of severity of clinical disease caused by West Nile Virus. The duration of immunity is at least 12 months.

Administration and Dosage: Shake well before use. Using aseptic technique, vaccinate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3-4 weeks using a different injection site. Revaccinate annually and prior to anticipated exposure with a single 1 mL intramuscular dose.

Precautions

Store at 2-7°C. Protect from freezing. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur following use. Antidote: Epinephrine. Preservatives: Gentamicin and Amphotericin B.

Manufactured by: Boehringer Ingelheim Vetmedica, Inc., St. Joseph, Missouri 64506 U.S.A.

U.S. Vet. Lic. No. 124

Manufactured for: Boehringer Ingelheim (Canada) Ltd., Burlington, Ontario L7L 5H4

1 Doses/1 mL

35410-00

10 Doses/10 mL

35408-02

NAC No.: 12301221

BOEHRINGER INGELHEIM (CANADA) LTD.
5180 SOUTH SERVICE ROAD, BURLINGTON, ON, L7L 5H4
Customer Care No.:   800-567-1885
Technical Services No.:   1-877-565-5501
Website:   www.boehringer-ingelheim.ca
Every effort has been made to ensure the accuracy of the Vetera WNV information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-07-28

(web1)